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Cytokine loci undergo changes in chromatin structure
when naive CD4+ T cells differentiate into Th1 or Th2
cells and have also been examined for regulatory se-
quences underlying such changes and their functional
correlates. Studies have shown that distal regulatory
elements control the Ifng and Th2 cytokine loci and
are primary targets for tissue-specific transcription
factors, serving as centers for epigenetic changes
that mark heritable traits in effector cells. Reports of
intra- and, remarkably, interchromosomal interactions
between these regulatory elements shed light on the
mechanisms by which they regulate gene expression,
revealing an extraordinary new picture that conceptu-
ally extends our views on how genes are regulated
from two to three dimensions. Here, we summarize
these recent findings on the role of regulatory ele-
ments and their mechanisms of action, which are of
broad significance for gene regulation, not only of
the immune system but also of many, if not all, coregu-
lated genes.
Introduction
Naive CD4+ T cells differentiate into Th1 or Th2 effector T
cells upon antigenic stimulation by antigen-presenting
cells. Th1 and Th2 cells perform distinct immune func-
tions; Th1 cells mediate cellular immunity against intra-
cellular bacteria and viruses, whereas Th2 cells enable
humoral immunity and immunity against extracellular
parasites. The effector functions of Th1 cells are exerted
in part by production of interferon (IFN)-g and lympho-
toxin-a and those of Th2 cells by interleukin (IL)-4,
IL-5, and IL-13. Dysregulation of these Th1 and Th2
cell functions, however, can cause autoimmune disease
and allergy, respectively.
The Th2 cytokine locus (Il4-Il13-Rad50-Il5 locus) and
Ifng locus, which are expressed in Th2 and Th1 cells, re-
spectively, undergo structural and epigenetic changes
during differentiation (Figures 1 and 2). These loci have
been studied extensively as a model system for gene
regulation and lineage-dependent chromatin changes
because of fundamental interests in the differentiation
process and their clinical implications. The studies in-
clude identification of regulatory sequences, analysis
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66160.of their function, and elucidation of the mechanisms of
gene regulation by these sequences. The Th2 cytokine
locus, arguably the best-characterized system, pres-
ents a complex picture because of its sheer size
(140 kb) and composition, containing diverse classes
of regulatory elements (Figure 2).
Several excellent reviews have discussed transcrip-
tion factors and lineage decision processes. In this re-
view, we will focus on recent findings on the genetic
analysis of key regulatory sequences in the Th2 cytokine
and Ifng loci, their epigenetic modifications, and the
mechanisms through which the regulatory elements
regulate cytokine gene expression by intra- and inter-
chromosomal interaction.
Regulatory Elements of the Th2 Cytokine
and Ifng Loci
The search for regulatory elements involved in gene reg-
ulation has utilized three principal methods. In the first
method, the DNase I hypersensitivity assay identifies
genomic regions that have a relatively open chromatin
structure due to a distorted nucleosomal array that con-
fers susceptibility to digestion by DNase I. The second
method involves the identification of conserved non-
coding sequences (CNS) between different species.
The rationale for this approach is that important regula-
tory sequences are likely to be conserved evolutionarily.
The third approach is functional analysis. Commonly,
the functional impact of elements discovered by DNase
I hypersensitivity and sequence alignment is then deter-
mined in reporter assays, transgenic mice, and knock-
out mice. In fact, functional analysis in bacterial artificial
chromosome (BAC) transgenic mice was used to iden-
tify the Th2 locus control region (LCR), followed by
DNase I hypersensitivity and sequence conservation
analysis to localize and define the LCR elements.
Th2 Cytokine Locus
The search for regulatory elements in the Th2 cytokine
locus using the methods described above has resulted
in the identification of several different types of regu-
latory elements, including enhancers, silencers, and a
locus control region. We will first describe each compo-
nent briefly and discuss the overall roles of the elements
in gene regulation.
Three hypersensitive sites (HS), termed HSS1–HSS3,
were originally described in the intergenic region be-
tween Il4 and Il13 (Takemoto et al., 1998). Of the three,
HSS1 and HSS2 are Th2 specific, whereas HSS3 is pres-
ent in naive CD4+ cells, Th1, and Th2 cells. In a separate
approach, Rubin and colleagues found highly con-
served regions, including CNS-1 and CNS-2 (Loots
et al., 2000); as it turned out, CNS-1 contained HSS1
and HSS2. To characterize the function of CNS-1, mu-
rine CNS-1 was deleted in the endogenous locus (Mohrs
et al., 2001) and human CNS-1 was deleted in yeast arti-
ficial chromosome (YAC) DNA containing the Th2 cyto-
kine locus (Loots et al., 2000). In both systems, deletion
of CNS-1 resulted in a reduction of cells producing IL-4,
IL-5, and IL-13, and it was suggested that CNS-1 is
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370Figure 1. Overview of Genetic, Epigenetic,
and Molecular Events Accompanying T
Helper Differentiation
General summary of epigenetic and struc-
tural changes of cytokine loci in naive, early
activated, and effector Th1 and Th2 cells. Cy-
tokine loci in naive CD4+ T cells exist in a rela-
tively inert epigenetic state, with H3 hypoace-
tylation and DNA methylation at these sites.
Both intra- and interchromosomal interac-
tions between alternatively expressed loci
are present. Upon antigenic stimulation, line-
age nonspecific increases are seen at the epi-
genetic and transcriptional levels, with both
IFN-g and IL-4 mRNA being expressed.
These changes are then reinforced and main-
tained in only the proper T helper subset,
contributing to the polarization of effector
Th1 and Th2 cells.a coordinate regulator of Th2 cytokine genes. Subse-
quent studies in transgenic reporter mice showed that
CNS-1/HSS has strong enhancer activity (Lee et al.,
2001), whereas other experiments revealed that CNS-1
appeared to be responsive to GATA-3 in chromatin re-
modeling and enhancer activity, consistent with demon-stration of potential GATA-3 sites by gel shift analysis
(Takemoto et al., 2000; Lee et al., 2001).
HSV was identified as a Th2-specific HS located 30 of
Il4 (Agarwal and Rao, 1998), overlapping with CNS-2.
HSVa was described as an activation-dependent HS lo-
cated close to HSV (Agarwal et al., 2000). In transientFigure 2. Detailed Map of Chromatin Structure throughout T Helper Differentiation
The Th2 cytokine and Ifng loci undergo lineage-specific chromatin changes during T helper differentiation. DNase I hypersensitive sites develop
during lineage commitment, in part defining elements of regulatory function. Such hypersensitivity coincides with regions of histone acetylation
and DNA demethylation, demarcating cis elements or areas of transcriptional activity. Depicted in the top panel is the entire 140 kb Th2 cytokine
locus and the epigenetic changes that accompany T helper development. The bottom panel summarizes such changes occurring in the Ifng lo-
cus. Illustrated in this figure are hypersensitive sites and sites of histone H3 hyperacetylation and DNA demethylation as symbolized in the key.
Genes are represented by thick, shaded bars with vertical lines protruding downward denoting the exons.
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371transfection and transgenic reporter assays, the combi-
nation of HSV and HSVa showed strong enhancer activ-
ity (Agarwal et al., 2000; Lee et al., 2001), where NFAT1
and GATA-3 bind to HSVa. HSV/CNS-2+HSVa knockout
mice showed reduced expression of IL-4, IL-5, and IL-13
in Th2 cells and mast cells (Solymar et al., 2002), with the
extent of reduction greater in mast cells. In Th2 cultures,
there is a mixture of IL-4-producing and –nonproducing
cells, and interestingly, restriction enzyme accessibility
of HSVa increases in the IL-4-producing cells, whereas
it is unchanged in IL-4-nonproducers, suggesting that
HSVa controls probabilistic expression of IL-4 (Guo
et al., 2004).
The intronic enhancer (IE), located within the second
intron of the Il4, was initially described as a mast cell-
specific HS (Henkel et al., 1992). It was later shown to
be hypersensitive in Th2 cells, but not in Th1 or naive
CD4+ T cells (Agarwal and Rao, 1998). Transgenic re-
porter assays showed that IE/HSII enhanced IL-4 pro-
moter activity and that IE in combination with CNS-1/
HSS conferred GATA-3-dependent enhancement of
IL-4 promoter activity (Lee et al., 2001).
HS1/CS1/CGRE is located 1.6 kb upstream of Il13 and
was described as a highly conserved Th2-specific HS
(Agarwal and Rao, 1998; Kishikawa et al., 2001; Yama-
shita et al., 2002). This region was shown to bind
GATA-3, CBP/p300, and RNA polymerase II, and it en-
hanced Th2 cytokine promoter activity in transient
transfection assays (Yamashita et al., 2002). However,
transgenic mice containing HS1-IL-4 promoter lucifer-
ase did not show any enhancer activity compared
to control IL-4 promoter-luciferase transgenic mice
(G.R. Lee and R.A. Flavell, unpublished data), suggesting
a discrepancy between the two assays.
HSIV is located at the 30 end of Il4 and is constitutively
hypersensitive in naive CD4+ T cells, Th1, and Th2 cells
(Agarwal and Rao, 1998). Recently, the location of HSIV
was finely mapped by using genomic DNA digested with
restriction enzymes as molecular weight markers (Ansel
et al., 2004). This newly revised location of HSIV (Ansel
et al., 2004) is slightly different from that originally re-
ported (Agarwal and Rao, 1998) and coincides with the
location of HM1 (Lee et al., 2001). Unlike the original as-
signed region of HSIV, the DNA sequence of HSIV/HM1
is highly conserved across many species (Ansel et al.,
2004; Lee et al., 2001). Surprisingly, HM1 reduced IL-4
promoter activity, suggesting repressor/silencer activity
(Lee et al., 2001). HSIV-deficient mice showed aber-
rant expression of IL-4 and IL-13 in Th1 cells, consis-
tent with the function of HSIV as a Th1-specific silencer
(Ansel et al., 2004).
An LCR is a regulatory region that comprises both en-
hancer and insulator activity; these confer high expres-
sion and insulation from the effects of neighboring chro-
matin on a given transgene. As a result, transgenic
constructs carrying an LCR exhibit copy number-
dependent tissue-specific expression. Because the Th2
locus comprises a cluster of cytokine genes (Il4, Il5, and
Il13) that are regulated in a differentiation-specific man-
ner, it was necessary to determine whether the Th2 cy-
tokine locus contains an LCR. The presence of an LCR
within the Th2 cytokine locus was first demonstrated
with reporter assays using transgenic mice containing
a BAC carrying the Th2 cytokine locus into which anIL-4 promoter-luciferase cassette was integrated (Lee
et al., 2003). These transgenic mice showed copy num-
ber-dependent expression of luciferase as well as IL-4
and IL-13. Subsequent deletion analysis showed that
the LCR was localized to the 30 end of Rad50. DNase I
hypersensitivity assays performed by our group and
Rao and colleagues independently identified four HS
sites (termed RHS4, RHS5/RAD50-O, RHS6/RAD50-
(A+B), and RHS7/RAD50-C) that comprise the Th2 cyto-
kine LCR (Fields et al., 2004; Lee and Rao, 2004). Among
these sites, RHS4, 5, and 7 are Th2 specific, whereas
RHS6 is constitutively expressed in naive CD4+ cells,
Th1, and Th2 cells in our study. In contrast to our study,
RHS5/RAD50-O is hypersensitive in both Th1 and Th2
cells in the study by Rao and colleagues; this difference
is probably due to the use of primary cells in one study
and cell lines in the other. RHS5, 6, and 7 are highly con-
served between species, and functional analyses in
transgenic reporter assays showed that the combina-
tion of these sites can recapitulate LCR function, sug-
gesting that they constitute the core of the Th2 LCR
(Fields et al., 2004). Among the HSs in the LCR, RHS7
was further analyzed in RHS7 knockout mice, which
showed a dramatic reduction of Th2 cytokine expres-
sion, confirming the role of the LCR in Th2 cytokine
gene expression (Lee et al., 2005).
In addition to meeting the classical definition of an
LCR, the Th2 cytokine LCR exhibited other hallmarks
that implicate a regulatory function for it. Most notably,
the Th2 LCR undergoes a series of epigenetic changes
in a lineage-specific pattern (Fields et al., 2004). The re-
gion encompassing RHS4-7 is hypoacetylated in naive T
cells. Upon TCR stimulation, this region becomes pref-
erentially hyperacetylated under Th2-polarizing condi-
tions, consistent with its increased hypersensitivity.
Moreover, one specific site in the LCR, RHS7, un-
dergoes a rapid and Th2-specific demethylation (Fields
et al., 2004). Interestingly, these changes appeared to
occur simultaneously with those observed at other im-
portant cis elements, in particular, the IL-4 and IL-13
promoters. These observations have yielded some of
the first insights as to how coordinated regulation might
be defined.
Ifng Locus
Three hypersensitive sites were described in the introns
of the Ifng gene: HS1 and HS2 in intron 1 and HS3 in in-
tron 3 (Agarwal and Rao, 1998). Transgenic reporter as-
says showed that a combination of intron 1 and intron
3 conferred strong enhancer activity, but not tissue-
specific expression to an IFN-g promoter reporter con-
struct (Soutto et al., 2002). In addition, transgenic mice
containing an 8.6 kb fragment spanning the human
Ifng gene showed high level expression of the gene
but lacked Th1 specificity, whereas a 191 kb fragment
containing the human Ifng locus showed high level,
Th1-specific expression, suggesting that distal regula-
tory elements are required for tissue-specific expres-
sion (Soutto et al., 2002; Young et al., 1989). Transient
transfection assays showed enhancer activity of intron
3 (Shnyreva et al., 2004). HS1 and HS3 both become ac-
cessible at the chromatin level upon Th1 stimulation of
CD4+ T cells as measured by increased restriction en-
zyme accessibility (Guo et al., 2004).
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372CNS-1 was discovered by the demonstration of DNA
sequence conservation between species and is located
5 kb upstream of the Ifng gene (Lee et al., 2004; Shnyr-
eva et al., 2004). CNS-1 demonstrated Th1-specific hy-
persensitivity and enhancer activity in transient trans-
fection assays. NFAT and T-bet bind to this region in
stimulated Th1 cell lines and augment enhancer activity
(Lee et al., 2004). Use of the chromosome conformation
capture (3C) method has recently shown that CNS-1 is
colocalized with the Ifng gene in the naive and Th1 T
cell nucleus (Spilianakis et al., 2005) because it shows
significantly greater signal in the 3C assay than control
GAPDH fragments only 560 bp apart (see below for a dis-
cussion of the 3C technique).
CNS-2 was also discovered by the analysis of DNA se-
quence conservation and is located 18 kb downstream
of the Ifng gene (Shnyreva et al., 2004). CNS-2 showed
enhancer activity in transient transfection assays, Th1-
specific DNase I hypersensitivity, and Th1-specific his-
tone acetylation. T-bet binds to CNS-2 and induces
a transcriptionally favorable chromatin structure (Shnyr-
eva et al., 2004). Again, 3C analysis has shown, interest-
ingly, that CNS-2 becomes colocalized with the Ifng
gene in Th1 cells, but these elements are not associated
in precursor naive T cells (Spilianakis et al., 2005).
Epigenetic Control of Th1/Th2 Differentiation:
Chromatin Remodeling of the Cytokine Loci
The regulatory sequences described above are the pri-
mary targets for binding tissue-specific transcription
factors and chromatin remodeling factors and serve as
platforms to initiate chromatin changes for transcrip-
tional activation. We now will describe the basic prin-
ciples of epigenetic changes and summarize the epi-
genetic changes that control Th1/Th2 differentiation
(summarized in Figure 2).
The DNA/histone complex, called a nucleosome,
forms the basic structural unit of chromatin. While this
arrangement of chromatin (DNA wrapped around the
cylinder-like histone core) enables the compaction of
DNA, it simultaneously impedes recognition by DNA
binding proteins. Thus, the structure is generally consid-
ered to be an impediment to transcriptional activity and
must be ‘‘remodeled’’ in order to allow local access of
transcriptional machinery. These changes accompany
induction or silencing of transcription and include, but
are not limited to, alterations in posttranslational modifi-
cations of histone tail residues and changes in DNA
methylation status. Actively transcribed or transcrip-
tionally competent gene loci generally exhibit increased
sensitivity to nucleases or restriction enzymes, in-
creased histone acetylation, and decreased CpG DNA
methylation.
Although mechanisms of chromatin remodeling are
multiple, an important contributing factor is the modifi-
cation of histone tails, which protrude from the core nu-
cleosomes and are accessible to a variety of modifying
enzymes. Acetylation has been the most widely studied;
however, recent work has correlated other modifica-
tions such as methylation, phosphorylation, and ubiqui-
tination with changes in transcriptional activity in a num-
ber of genes (Cheung et al., 2000; Strahl and Allis, 2000;
Wei et al., 1999; Baarends et al., 1999; El-Osta and
Wolffe, 2000; Turner, 2000). Those modifications of his-tone H3 that are positively correlated with transcrip-
tional activity are acetylation of lysines 9 and 14 and
methylation of lysine 4. The combination of these modi-
fications is thought to demarcate ‘‘active chromatin do-
mains’’ within a gene locus and is often associated with
regulatory regions such as promoters and enhancers. In
contrast, methylation of lysines 9 and 27 are associated
with gene silencing.
The mechanisms by which histone modifications alter
gene locus activity are not completely understood. One
way in which this control is exerted is by altering nucle-
osomal architecture such that DNA binding is changed,
either allowing or restricting access to DNA binding pro-
teins. Another facet of this regulation may lie in the abil-
ity of a modified histone or CpG to serve as a template
for binding of a variety of chromatin-modifying ele-
ments. This binding can occur in a combinatorial fashion
and thus adds an additional layer of complexity to regu-
lation by this mechanism (Strahl and Allis, 2000). This va-
riety of permutations and potential regulatory scenarios
is referred to as the ‘‘histone code.’’
Another chromatin modification, CpG methylation of
DNA, promotes gene silencing through a number of pro-
posed mechanisms (Wilson et al., 2005). The methyl
CpG binding proteins MBD2 and MeCP2 recruit com-
plexes containing histone deacetylases (HDAC) and co-
repressors (Nan et al., 1998; Jones et al., 1998), and they
may also prevent transcription factors and coactivators
from binding to methylated promoters and enhancer re-
gions. Thus, demethylation serves to derepress a locus,
presumably through reversal of the aforementioned ac-
tions. Interestingly, HDAC recruitment by methyl-CpG
binding proteins implicates an interplay between his-
tone modifications and DNA methylation, perhaps allud-
ing to the existence of a higher order system of combi-
natorial modifications beyond the histone code.
In early studies of DNA methylation of the Ifng gene,
Young and colleagues made the first correlation be-
tween alterations in DNA structure and cytokine tran-
scription (Farrar et al., 1985). In these studies, the pre-
vention of DNA methylation by 5-azacytidine treatment
led to expression of IFN-g by cells that did not ordinarily
express the cytokine. It was later demonstrated that
changes in DNA methylation resulted not only in
changes in transcription but also in alterations in the lo-
cal chromatin environment surrounding that gene (Ce-
dar 1988). Thirteen years after these studies, the first de-
finitive evidence of chromatin changes playing a role in
differential cytokine expression by T cell subsets was
obtained (Agarwal and Rao 1998; Bird et al., 1998).
Rao and colleagues identified T cell lineage-specific
DNase I hypersensitive sites near the Il4 and Ifng genes.
These sites were found near promoter and enhancer re-
gions in both gene loci (Agarwal and Rao 1998). Concur-
rent studies with HDAC inhibitors and 5-azacytidine
identified a role for epigenetic events in regulation of
transcription of the Th1/Th2 cytokines, confirming the
importance of these events in T cell fate determination
(Bird et al., 1998; Valapour et al., 2002).
That HDAC inhibition resulted in increased expression
of IL-4 and IFN-g provided indirect evidence for a role for
histone acetylation in Th1/Th2 differentiation. More
recent studies using chromatin immunoprecipitation
(ChIP) directly demonstrated that changes in histone
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373acetylation at the cytokine loci accompany Th1/Th2 dif-
ferentiation (Fields et al., 2002; Avni et al., 2002; Yama-
shita et al., 2002; Messi et al., 2003). While the cytokine
loci in naive T cells are relatively unacetylated, hyper-
acetylation occurs on histones in the Th2 cytokine locus
in Th2 cells and in the Ifng locus in Th1 cells after T cell
stimulation. Time-course studies showed that initially
the increased acetylation occurs on both loci indepen-
dently of polarizing conditions. Lineage- and locus-spe-
cific patterns subsequently emerge and are reinforced
by cytokines in a STAT-dependent manner. The hyper-
acetylation appears to be focused at promoters and
other regulatory regions such as enhancers and the
Th2 LCR. This suggested that the acetylation patterns
‘‘mark’’ the loci, maintaining their transcriptional compe-
tence in a lineage-specific fashion. This epigenetic mark
persists in cells not actively transcribing the cytokines
and thus may contribute to the maintenance of the cells’
identities as either Th1 or Th2. Studies in murine, mem-
ory CD4+ T cells support this hypothesis. Like effector T
cells generated in vitro, the cytokine gene acetylation
patterns in antigen-specific, effector, and central mem-
ory T cells showed Th1/Th2 polarization in vivo (Yama-
shita et al., 2002).
Although hyperacetylation correlates positively with
transcriptional competence and may mark a gene locus
for activity, its absence does not necessarily correlate
with gene silencing. After polarizing freshly isolated, na-
ive human T cells into Th1 or Th2, the cells were repolar-
ized into the opposite phenotype. These repolarized
cells showed increased acetylation at the formerly hypo-
acetylated cytokine locus, with no reduction of acetyla-
tion at the originally activated locus (Messi et al., 2003).
These changes in acetylation correlated with plasticity
in cytokine transcription. These results clearly demon-
strated that hypoacetylation at an inactive cytokine
gene locus can be reversed upon T cell stimulation un-
der appropriate conditions and that this plasticity of lo-
cus activation enables the cell to be flexible in the type of
responsiveness that it can mediate (Th1 versus Th2).
In a similar manner as hyperacetylation, DNA deme-
thylation seems to correlate in general with the activa-
tion and transcriptional competence of cytokine gene
loci as was found many years ago for other loci such
as b-globin (van der Ploeg and Flavell, 1980). Various
studies have established that in Th2 cells key cis ele-
ments in the Th2 cytokine locus undergo demethylation,
including the IL-4 and -13 promoters and CNS-1 and -2
(Fields et al., 2004; Lee et al., 2002; Guo et al., 2002, San-
tangelo et al., 2002). There are, however, areas of hypo-
methylation already present in naive T cells in the IL-4
promoter (Fields et al., 2004) and CNS2 region (Lee
et al., 2002). Once these sites of demethylation are es-
tablished, they are maintained in a demethylated state
and coincide with DNase hypersensitivity and hyperace-
tylation (Makar et al., 2003; Fields et al., 2002, 2004; Lee
et al., 2002; Santangelo et al., 2002). Although it has not
been shown that demethylation is sufficient to effect
transcription, it is permissive (Busslinger et al., 1983),
and ectopic expression of cytokine genes in 5-azacyti-
dine-treated or MBD2-deficient T cells at least impli-
cates a role for DNA methylation in maintaining a si-
lenced state (Bird et al., 1998; Hutchins et al., 2002).
MBD2-deficient Th1 and Th2 cells produce IL-4 andIFN-g ectopically, and these conditions are exacerbated
in the presence of the HDAC inhibitor trichostatin A
(TSA), implicating a cooperative role of DNA methylation
and histone hypoacetylation in silencing cytokine loci
(Hutchins et al., 2002). Similarly, Dnmt1-deficient T cells
exhibit increased ectopic production of cytokines in in-
appropriate cell types (Makar et al., 2003). Here, such
derepression correlates with a general hypomethylation
across the Il4 locus due to lack of Dnmt1 recruitment to
the IL-4 promoter and intronic enhancer in Th1 cells.
That GATA-3 expression is dispensable or unaffected
in these knockout animals demonstrates an elegant
mechanism of bypassing conventional transcriptional
programs to activate cytokine loci solely through epige-
netic alterations.
There is increasing evidence for the role of DNA meth-
ylation in governing cytokine expression developmen-
tally before and after T helper differentiation. For exam-
ple, a pattern of hypomethylation at the IFN-g promoter
is established early in T cell development as well as in
naive CD8+ and NK populations, but not in B or nonhe-
matopoietic cells. This hypomethylation, indicative of
a predisposition for IFN-g production, is maintained in
Th1 cells, but this region becomes remethylated during
Th2 development, conditions under which IFN-g is not
expressed (Yano et al., 2003; Winders et al., 2004).
Here, methylation of DNA silences a locus as a function
of terminal differentiation. On the other hand, the newly
identified CIRE (conserved intron 1 sequence of Il4) un-
dergoes demethylation only in IL-4-secreting Th2 cells,
which the authors argue explains in part the basis for
memory expression of IL-4 (Tykocinski et al., 2005).
Thus, DNA demethylation also potentiates heritable
and stable gene expression during the transition from
effector to memory T cell.
Very little is known about the transcription factors that
mediate epigenetic changes at the cytokine loci. In the
Il4 and Ifng loci, cytokine signaling via the STAT proteins
has been shown to be a critical determinant of polarized
acetylation (Avni et al., 2002; Fields et al., 2002). In the
absence of STAT6, neither Il4 locus histone acetylation
nor DNA demethylation is completely established
(Fields et al., 2002; Lee et al., 2002). Likewise, in
STAT4-deficient T cells, IFN-g promoter acetylation
does not occur. Although these proteins have been
shown to bind directly to the gene loci, whether their ef-
fects result from recruitment of histone acetyltransfer-
ase or from indirect action has not yet been determined
(Morinobu et al., 2004; Avni et al., 2002). The roles of the
downstream activators GATA-3 and T-bet appear to be
more complicated than that of the STATs. Enforced, ec-
topic expression of these proteins is sufficient to induce
chromatin changes in the cytokine loci. For example,
GATA-3 can induce DNase I hypersensitivity and tar-
geted hyperacetylation in the Il4 locus (Ouyang et al.,
2000; Takemoto et al., 2000; Lee et al., 2000; Fields
et al., 2002). Likewise, overexpression of T-bet can in-
duce similar changes in the Ifng locus (Fields et al.,
2002, Mullen et al., 2001). Whether these act directly
on the loci or indirectly has not been established. The
necessity of these factors in inducing acetylation
changes has been examined by using T cells with tar-
geted mutations of these factors. In T-bet-deficient T
cells, which are defective in developing Th1 responses,
Immunity
374hyperacetylation in the IFN-g promoter fails to develop
(Avni et al., 2002). In conditional GATA-3-deficient T
cells, normal Th2 acetylation patterns in the Il4, Il5, and
Il13 genes are impaired (Yamashita et al., 2004). The ef-
fect is most prominent in the Il5gene, where there is a se-
vere loss of Th2-associated hyperacetylation. The effect
in the Il4 and Il13 genes is much less pronounced.
The effect of GATA-3 loss on Th2 cytokine production
is more apparent in developing responses than in estab-
lished Th2 cells. In a developing Th2 response, loss of
GATA-3 results in the inability to effectively mount
a Th2 response, with a substantial reduction in the gen-
eration of IL-4-, IL-5-, and IL-13-producing cells (Pai
et al., 2004; Zhu et al., 2004; Yamashita et al., 2004). In
contrast, the loss of GATA-3 in established Th2 cells
causes a dramatic reduction in IL-5 production, a smaller
effect on IL-13, but little effect on IL-4 (Pai et al., 2004;
Zhu et al., 2004). GATA-3 acts in part by maintaining hy-
peracetylation of promoter regions of the Il5 gene. The
maintenance of acetylation patterns and transcriptional
activity of the Il4 and Il13 genes may be controlled by ad-
ditional mechanisms.
While acetylation has been extensively studied, other
histone modifications in the cytokine loci have recently
begun to be analyzed. In particular, histone H3 methyla-
tion has been documented during Th1/Th2 differentia-
tion. Lysine 4 methylation has been analyzed in the Il4
and Ifng loci and generally matches those patterns ob-
served with lysine 9/14 acetylation (Yamashita et al.,
2004; Baguet and Bix 2004). Recently, lysine 27 (H3/
K27) methylation has been examined in the Th2 cytokine
locus and was found to be present across the Il4 and Il13
genes preferentially in Th1 cells (Koyanagi et al., 2005).
Correlated with this was the localization of the H3/K27
methyltransferase Ezh2 with the same region. Thus,
this modification, known to be associated with gene si-
lencing, likely plays a role in repression of IL-4 and IL-13
expression in Th1 cells.
We have discussed regulatory elements and epige-
netic controls for Th1/Th2 differentiation. Now, we will
turn to the mechanisms through which the loci are regu-
lated at the molecular level. Technological advances in
determining the spatial organization of chromatin have
enabled the study of the dynamic changes that occur
during cell differentiation. Recent studies of the Th2 cy-
tokine and Ifng loci using this technology have high-
lighted the role of the Th2 LCR and shed light on its
mechanism of locus regulation.
LCRs and Their Mode of Action
LCRs have three major characteristics as defined in
transgenic reporter assays. They confer tissue-specific
expression of linked genes at physiological levels in
a position-independent, copy number-dependent man-
ner. LCRs have the ability to incorporate the action of an
enhancer as well as an insulator and that is how they are
able to activate a gene irrespective of the site of integra-
tion in the genome. The components of an LCR usually
colocalize with a series of DNase I hypersensitive sites
in the chromatin of expressed genes. These sites are oc-
cupied by ubiquitously expressed as well as tissue-spe-
cific factors.
Numerous DNA elements have been described in
mammals that meet the criteria for LCR function (Liet al., 2002). The concept, discovery, and definition of
the LCR derives from pioneering studies in the b-globin
locus (Grosveld et al., 1987) and still most of the data
presented so far for LCR function come from studies
of the b-globin LCR (human, murine, and chicken) (Fes-
tenstein and Kioussis, 2000; Fraser and Grosveld, 1998,
1999; Li et al., 1999b). This LCR consists of five DNase I
hypersensitive sites, the first four of which are erythroid
specific and the fifth is found in multiple cell lineages
(Li et al., 1999a). The first application of 3C analysis
to mammalian genes (see below) identified an ‘‘active
chromatin hub’’ at which the LCR hypersensitive sites
contact the promoter of the gene being expressed at
a given time via loops. For the b-globin locus, this occurs
in a developmentally regulated manner, such that at
later times a new gene/promoter is recruited to the
hub, presumably enabling this gene to be expressed
(Palstra et al., 2003; Tolhuis et al., 2002). Other examples
include those of the human cd2 locus (Festenstein et al.,
1996; Lang et al., 1991), the T cell-specific TCRa LCR
(Diaz et al., 1994), which confers tissue-specific DNA de-
methylation, the murine immunoglobulin heavy chain
(IgH) LCR (Madisen and Groudine, 1994), and many
others.
The Th2 LCR and the Coordinate Expression
of Three Genes
The discovery of the b-globin LCR and the characteriza-
tion of LCRs in other systems like that of the Th2 cyto-
kine locus suggest that tissue-specific, developmentally
regulated gene transcription relies not only on gene-
proximal elements but also on long-range interactions
of various cis-regulatory elements and complex second-
ary chromatin configurations (Li et al., 2002). Although
defined by many criteria, there was no clear mechanism
suggested for the mode of action of the Th2 LCR in co-
ordinately regulating the three Th2 cytokine genes.
Again derived from the paradigm of the globin model,
according to the looping model (Choi and Engel, 1988),
an LCR is occupied by activating transcription factor
complexes that come in close proximity to a promoter
and activate a gene by looping out the intervening chro-
mosomal region between the LCR and the promoter.
The first elucidation of the active chromosome hub for
the b-globin locus by 3C analysis provided a molecular
basis for LCR function in regulation of gene expression
during development (Palstra et al., 2003; Tolhuis et al.,
2002). Thus, LCRs can confer their function even when
located at great distances from their target gene(s) (Dek-
ker, 2003). However, how the expression of three core-
gulated genes—Il4, Il5, and Il13—was controlled by an
LCR was unclear. Using 3C (Tolhuis et al., 2002), it was
shown that the Th2 cytokine locus forms an initial core
complex in which the Th2 LCR can exert its activating ef-
fects by direct physical interaction (Spilianakis and Fla-
vell, 2004). In naive T cells and NK cells (which share
a common lymphoid progenitor), a cell-specific chroma-
tin core is formed between the participating Th2 genes
(Il4, Il5, and Il13), the enhancers in the locus (including
CNS1), and the Th2 LCR; in contrast, this conformation
does not exist in B cells or fibroblasts. Earlier studies
on LCR function showed enhancement of IL-4 and
IL-13, but not IL-5 (Lee et al., 2003). This result was con-
firmed by the strong interaction of the LCR with the Il4
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375Figure 3. Two Levels of a Poised Chromatin Configuration in the Th2 Cytokine Gene Locus
(A) Schematic representation of the Th2 cytokine gene cluster. All characterized DNase I hypersensitive sites are indicated by arrows.
(B) An initial chromatin configuration is detected in non-T cell lineage cells, such as fibroblasts and B cells (left). Additionally, in CD4+ T cells, in
this preformed chromatin configuration, the Th2 LCR confers its regulatory effects either in cytokine-expressing (Th2, right) or nonexpressing
cells (naive T cells and Th1 cells, middle). The expression and recruitment of cell-specific factors to a poised chromatin complex potentiates
the expression of Th2 cytokines in a Th2 cell.and Il13 genes, but not with the Il5 gene as shown by 3C
analysis (Figure 3) (Spilianakis and Flavell, 2004). Upon
differentiation, Th2 cells express cell-specific transcrip-
tion factors that are rapidly recruited to the preformed
chromatin complex generated by the Th2 LCR and the
genes it regulates. Thus, this provides an explanation
in molecular terms as to how an LCR can coordinately
regulate three genes in a given cell type. The Th2 LCR
can, in this way, coactivate the three cytokine genes par-
ticipating in a preformed chromatin configuration with-
out affecting the constitutively expressed Rad50 gene,
which is looped out of the active chromatin hub. It re-
mains to be seen whether cell-specific transcription fac-
tors such as GATA-3 and STAT6 act as the platform for
the recruitment of remodeling complexes or other pro-
teins and thus confer specificity of recruitment of these
complexes to a locus where transcription is ready to be
initiated.
Prepoised and Poised Gene Chromatin
Configuration in the Th2 Cytokine Locus
These studies have shown that the promoters of the Th2
cytokine genes come into close spatial proximity to form
a ‘‘prepoised’’ core chromatin configuration in cells of
the T cell lineage that either express (Th2) or do not ex-
press (naive T cells, Th1) these cytokine genes (Spiliana-
kis and Flavell, 2004). This configuration is also found in
NK, B cells, and fibroblasts. Within this core complex incells of the T and NK cell lineages, the LCR further con-
tributes to this higher order chromatin conformation to
generate a ‘‘poised’’ state. It has already been described
for several systems that a transcriptional complex can
be formed on a promoter, but transcription is not initi-
ated because the C-terminal domain of RNA polymerase
II is not phosphorylated (Boehm et al., 2003; Gilmour and
Lis, 1986; Graunke et al., 1999; Ljungman and Hanawalt,
1995; Spilianakis et al., 2003; Wang et al., 1997). The
b-globin LCR acquires such a conformation, interacting
with other DNase I hypersensitive sites in the locus in
erythroid progenitors that do not express the b-globin
genes (Palstra et al., 2003). The phenomenon in which
a locus is heritably poised for gene expression even
when it is transcriptionally inactive may be a unique fea-
ture of genes that require rapid transcriptional induction
in response to a stimulus (Smale and Fisher, 2002). CD4+
naive T cells, Th1, and Th2 cells initially have the poten-
tial to express Th2 cytokines with regard to their chro-
matin conformation, but additional cell-specific factors
and posttranslational histone modifications of chroma-
tin determine whether a given event occurs.
Transcription Factors Important for the Action
of the Th2 LCR
Naive CD4+ T cells produce low levels of IL-4 in a STAT6-
independent manner, (Grogan et al., 2001) with peak
mRNA production occurring 2–3 hr poststimulation
Immunity
376(Grogan et al., 2001; Spilianakis et al., 2005). We hypoth-
esize, taking into consideration recent data regarding
the looped conformation of the Th2 locus, that early ex-
pression of the Th2 cytokines is supported by the initial
poised chromatin configuration, but in later develop-
mental stages, such as in polarized effector cells,
STAT6 is important for the sustained tissue-specific ex-
pression of the Th2 cytokines, where additional factors
may be needed to mark and maintain the memory of epi-
genetic modifications. Thus, STAT6 is necessary for the
formation or maintenance of a secondary chromatin
conformation in later stages of differentiation, but other
factors are required to generate the prepoised confor-
mation already found in nondifferentiated naive cells.
Another downstream effector of STAT6 is GATA-3,
a factor important for the expression of Th2 cytokines
(Zheng and Flavell, 1997) and the formation and/or main-
tenance of interactions between the Th2 LCR and the
Th2 cytokine gene promoters (Lee et al., 2005). We sug-
gested that GATA-3 might coordinately affect the ex-
pression of Il4, Il5, and Il13 in the Th2 cytokine locus, ex-
erting its action on an already preformed, prepoised,
chromatin configuration (Spilianakis and Flavell, 2004).
Moreover, because GATA-3 can induce chromatin re-
modeling activity (Ouyang et al., 2000; Takemoto et al.,
2000, 2002; Lee et al., 2000), it may facilitate the forma-
tion or maintenance of the interaction between the Th2
LCR and the promoters of the target cytokine genes.
GATA-3 may cooperate with other tissue-specific tran-
scription factors for these functions. One example is co-
operative binding with NFAT by TCR stimulation. TCR
stimulation followed by calcium mobilization leads to
the rapid dephosphorylation of NFAT proteins and their
subsequent translocation to the nucleus where they ex-
hibit increased affinity for DNA binding (Rao et al., 1997).
Transcription-activating protein complexes consist of
NFAT dimers and NFAT/GATA family members hetero-
dimers among other components (Okamura and Rao,
2001).
Interchromosomal Interaction of the Th2
and Ifng Loci
Regulation of gene loci from genetic regulatory ele-
ments is based on the binding of transcription factors
and chromatin remodeling proteins that may bring into
close proximity genes whose expression has to be coor-
dinately regulated.
As discussed previously, upon stimulation of naive
CD4+ T cells and prior to their final differentiation into
Th1 or Th2 cells, an early burst of transcription occurs
for both the Il4 and Ifng genes that is dependent on stim-
ulation but independent of cytokine signaling (Ansel
et al., 2004; Grogan et al., 2001; Guo et al., 2004; Spilia-
nakis et al., 2005). This observation led us to utilize the
3C technique to test the hypothesis that this could be
mediated via physical interactions between the Ifng lo-
cus and the Th2 LCR. We found that the Ifng gene,
among other interactions, physically interacts with
RHS6 of the Th2 LCR. These data were also confirmed
at the single cell level by using fluorescent in situ hybrid-
ization (FISH), showing that in almost 40% of all naive
CD4+ T cells, the two loci were seen in close proximity
(Spilianakis et al., 2005). Upon differentiation of helper
T cells under either Th1 or Th2 conditions, the interac-tions between the loci wane and intrachromosomal in-
teractions are favored. Resting naive CD4+ T cells do
not express IFN-g or Th2 cytokines, but upon activation,
they express both rapidly without the presence of key
transcription factors. We therefore speculate that the in-
teractions between these two loci most likely hold the
Ifng and Il4 gene complexes together in a poised state,
ready for transcription, but not allowing active transcrip-
tion to take place.
It was recently reported that GATA-3 and T-bet are ex-
pressed at low but detectable protein levels in naive
CD4+ cells and physically interact through tyrosine
phosphorylation of T-bet as shown in coimmunoprecipi-
tation assays (Hwang et al., 2005). This study was yet an-
other example of an interaction, at the protein level, of
two products with exclusive function in Th1 and Th2
cells. It would be interesting to investigate the possibility
that these two factors are coupled in naive T cells and
bind at the Th2 (GATA-3) and Th1 (T-bet) loci to provide
the interaction that holds these two chromosomes to-
gether. This could be tested in mice lacking either
GATA-3 and/or T-bet and provide a clear answer for
the involvement of these two key transcription factors
in this phenomenon. Of major interest would also be
the characterization of the protein complexes bound to
the Th2 LCR and the identification of protein complexes
with specific remodeling activity acting at long dis-
tances in chromatin rather than at promoter and en-
hancer elements. Among many approaches, yeast one-
hybrid assays utilizing DNA baits that span the different
DNase I hypersensitive sites of the Th2 LCR could be
used to identify such protein complexes.
Future Directions
It remains to be seen how the inter- and intrachromoso-
mal cytokine gene complexes that we have described
converge with epigenetic changes to effect gene tran-
scription. We know that many of these events happen
concurrently, but it is unknown whether paradigms ob-
served in other LCRs are mirrored in the cytokine gene
system. For example, deletion of a specific HS in the
TCRa LCR precludes demethylation of a downstream
HS (Santoso et al., 2000). Do certain elements of the
Th2 LCR enable epigenetic changes in other regulatory
elements in the locus? Conversely, do any of these
changes allow for the association or dissociation of ge-
netic loci?
As discussed in this review, several approaches have
been employed to understand gene regulation in the im-
mune system and specifically the mechanisms of Th1/
Th2 differentiation. First was the characterization and
genetic manipulation of cis-acting elements and trans-
acting transcription factors that regulate T helper cell
expression patterns. Second, recent advances in dis-
secting the histone code and the regulation of DNA
methylation have added one more level of complexity
but have also helped to elucidate complex gene activa-
tion pathways. Third, the recent elucidation of the orga-
nization of these loci in the nucleus and the surprising
and unprecedented discovery of interactions between
regulatory components of cytokine loci on different
chromosomes have bred exciting new areas for study
of this interesting problem. The implications of the find-
ing of interchromosomal interactions are significant. We
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377can now consider regulatory elements like LCRs, en-
hancers, and silencers not only as regulatory elements
with special features acting in cis to drive the expression
of certain genes but also as genetic elements that can
act across multiple chromosomes in trans with pleiotro-
pic functions such as nuclear relocalization of loci and
the regulation of gene expression not only on the same
chromosome but also on different chromosomes.
Many exciting issues remain to be resolved: are these in-
teractions stable or transient, and are there alternative
configurations for a given element like the Th2 LCR?
The next years will yield these answers. It is highly likely
that this kind of interaction will not just be a property of
cytokine genes but, instead, a general feature of gene
organization. Interesting candidates for interchromo-
somal gene regulation are the immunoglobulin heavy
and light chain genes, where rearrangement must be
controlled in a temporal and locus-specific fashion, the
a- and b-globin genes, where the level of expression of
two genes must be balanced and the genes expressed
matched to the developmental stage, and olfactory re-
ceptor genes, where a choice to express a single gene
among many located on multiple chromosomes must
be made. Finally, a potential contribution of these kinds
of interactions between different chromosomes to the
common chromosomal translocations seen in tumors
should be explored.
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